This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

Dr. Kumiko Ui-Tei, PhD
CTO, ANRis Therapeutics and Director/Professor NucleoTIDE & PepTIDE Drug Discovery Center at Institute of Science Tokyo
Speaker

Profile

Kumiko Ui-Tei is a Director and Professor at the NucleoTIDE and PepTIDE Drug Discovery Center, Institute of Biomedical Engineering, Institute of Science Tokyo. She also serves as a Project Researcher at the Graduate School of Science, the University of Tokyo, and a Visiting Professor at the Center for Nucleic Acid Drug Development, Tokyo University of Science. She is a Co-founder and a Chief Technology Officer (CTO) of ANRis Therapeutics, a biotech startup established in 2023 to advance the real-world implementation of SNPD-siRNA therapeutics. In 2019, she received the Academic Award of the Nucleic Acids Therapeutics Society of Japan in recognition of her outstanding contributions to the field.

Agenda Sessions

  • Precision-Engineered SNPD-siRNAs for Allele-Specific Silencing of Disease-Causing Mutations

    1:45pm